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elevations but approaching 0 as the amplitudes decrease. We there-
fore propose a single-cell bi-parametric analysis that correlates the
rate of matrix Ca2+ extrusion with the amount of Ca2+ uptake, to
determine the impact of NCLX and Letm1. Over-expression of NCLX
revealed enhanced mitochondrial Ca2+ extrusion in cells with initial
high accumulation of Ca2+ into the matrix. On the other hand,
expression (or depletion) of Letm1 had no impact on Ca2+ extrusion,
at any level of matrix ion. Ca2+ has a dual effect on mitochondrial
redox status, stimulating Ca2+-activated dehydrogenases (reducing)
and accelerating respiration with associated enhanced formation
of reactive oxygen (oxidizing). The histamine-induced Ca2+ rise
increased the signal of the redox sensitive probe roGFP showing that
this physiological Ca2+ rise causes a net reduction of the matrix.
Enhancing Ca2+ extrusion following NCLX over-expression abolished
the Ca2+ effect. Consistent with these ﬁndings, the matrix Ca2+ rise
increased cellular NAD(P)H; an effect strongly reduced following
NCLX over-expression. Pharmacological inhibition of mitochondrial
Ca2+ extrusion, completely rescued both the reduced matrix redox
status and NAD(P)H production in NCLX-expressing cells.
We conclude that the extrusion of mitochondrial matrix Ca2+ is
mediated by NCLX but not by Letm1. By controlling the duration of
matrix Ca2+ rises, NCLX contributes to the regulation of NAD(P)H
production and modulates the mitochondrial redox state.
doi:10.1016/j.bbabio.2012.06.236
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Neuroﬁbromatosis type-1 is an autosomal dominant genetic
disorder affecting one in 2500/3500 persons worldwide. It is caused
by loss-of-function type mutations in the NF1 gene which encodes
for the protein neuroﬁbromin (Nf1) and predisposes patients to
tumor development following additional mutations on the remaining
normal allele.
Neuroﬁbromin is a large polypeptide, ubiquitously expressed,
with a functional GTPase-activating protein (GAP) domain by which
it negatively regulates the activity of the proto-oncoprotein p21-Ras.
Therefore, NF1 acts as a typical tumor suppressor gene. However, the
phenotype of NF1 patients is complex and variable, and efforts to
clearly deﬁne the molecular pathology of the disease need a complete
characterization of the biochemical functions of the Nf1 protein.
Indeed, apart from the GAP domain, the remaining 90% of neuro-
ﬁbromin is poorly characterized, and it is likely to harbour additional
domains and to be involved in other signalling pathways with an
unclear relevance for the onset and development of the NF1-
associated phenotype. Our group has previously shown that the
Ras/ERK signalling axis has a mitochondrial branch (Rasola A. et al.,
PNAS 2010), whose biological function is only partially understood.
Here we have investigated whether the hyperactivation of the Ras
signalling pathway induced by neuroﬁbromin inactivation can affect
mitochondria bioenergetics. We report that NF1−/− mouse embry-
onic ﬁbroblasts (MEFs) have a decreased Oxygen Consumption
Rate (OCR) and a lower Complex I (NADH dehydrogenase) activity
compared to wild type MEFs, suggesting that KO cells have a more
glycolytic metabolism. This metabolic switch (Warburg effect) is a
typical marker of cancer cells that favours tumor progression.
Accordingly, we observe that the absence of neuroﬁbromin confers
to MEFs the capability to form colonies in an in vitro tumorigenesis
assay, and that the use of an ERK inhibitor completely abrogates
colony formation. We hypothesize that Ras/ERK signalling is up-
stream to the regulation of mitochondrial bioenergetics, and that the
metabolic rewiring prompted by Ras/ERK activation can contribute to
the transformed phenotype that we observe in NF1−/− MEFs.
doi:10.1016/j.bbabio.2012.06.237
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Cell adaptation to hypoxic conditions is initiated by stabilization
of HIF1α, in coordination with reactive oxygen species (ROS) burst
originating in Complex III of respiratory chain. In principle, ROS
oxidize Fe2+ of proline hydroxylase domain enzymes and/or of
asparagine hydroxylase FIH [1], which leads to HIF1α stabilization, its
further dimerization with HIF1β in nucleus and subsequent regula-
tion of N100 proper gene expression. Canonical response leads to
suppression of mitochondrial ATP production/ oxidative phosphory-
lation in favor to glycolytic metabolism [2,3]. Such response involves
elevation of glycolytic enzymes, lactate dehydrogenases included;
and drop of mitochondrial oxygen consumption caused by inactiva-
tion of pyruvate dehydrogenase by its kinase. In contrast, we have
found that hepatocellular carcinoma HepG2 cells metabolizing glu-
tamine and galactose at aglycemia, thus preferentially providing ATP
by oxidative phosphorylation, do maintain respiration in hypoxia
(5% O2). Moreover, their respiratory chain performance runs in
optimal way, thus superoxide production extensively falls down to
~10%. This revealed phenotype is regulated in HIF-dependent manner
as HIF1α stabilization at 5 h in 5% O2 was observed with parallel ROS
burst initiating HIF pathways. Interestingly, observed morphology
changes of mitochondrial network after hypoxic adaptation were not
dependent on energy metabolism of the cell. They were pronounced
as a thinner, cobweb-like mitochondrial network, compared to atmo-
spheric conditions.
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Nm23-H4 forms symmetrical hexameric complexes in the mito-
chondrial intermembrane space and is proposed here to have two
different functions in mitochondrial metabolism. Nm23-H4 is known
for its phosphotransfer activity as an isoform of nucleoside diphos-
phate kinase [1]. By using mitochondrial ATP, it regenerates GTP
and other nucleoside triphosphates e.g. for mitochondrial GTPases
like OPA1, with which Nm23-H4 also interacts as shown here by
immunoprecipitation. This enzymatic reaction also regenerates ADP,
which stimulates respiration as we have shown earlier [2]. However,
Nm23-H4 also interacts with anionic phospholipids, mainly cardi-
olipin in the inner mitochondrial membrane [2,3] and can induce
membrane domains enriched in cardiolipin [4]. Such binding to
anionic lipids is essential for a putative second function of Nm23-H4,
intermembrane lipid transfer, as we reported in an earlier in vitro
study [5]. Here we show that anionic lipids inhibit the pho-
sphotransfer activity of Nm23-H4, suggesting a lipid-dependent
switch from phosphotransfer to lipid transfer activity. We further
provide evidence that intermembrane cardiolipin transfer by Nm23-
H4 occurs in vivo. Hela cells devoid of immuno-detectable amounts
of Nm23-H4 and stably expressing wild-type or membrane-binding
incompetent mutant were analyzed for mitochondrial lipid dis-
tribution by electro-spray ionization mass spectrometry. Only the
presence of Nm23-H4 wild-type, but not of membrane-binding in-
competent mutant, led to a partial collapse of cardiolipin asymmetry
between inner and outer mitochondrial membrane. These changes
are cardiolipin-speciﬁc as the distribution of phosphatidylcholine
remained unchanged in both HeLa cell lines. We propose that Nm23-
H4 is a part of a machinery that is involved in cardiolipin trafﬁcking
and thus has a dual function within mitochondria.
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In a previous study, we demonstrated that Cisd2 deﬁciency leads
to abnormalities of the structural integrity and function of mitochon-
dria. However, the physiological functions of Cisd2 in a speciﬁc
cell type remain unclear. It is unknown as to how the loss of Cisd2
causes metabolic defects in patients with the Wolfram syndrome
type 2 (WFS2). White adipose tissue (WAT) is an integrator in the
maintenance of energy metabolism and glucose homeostasis in the
human. In this study we showed signiﬁcant reduction of adiposity,
decrease in the size and weight of epididymal WAT and expression of
adipogenic genes in conventional Cisd2−/− mice compared with the
age-matched wild-type mice. Based on these results, we hypothesize
that Cisd2 is essential for the development and function of the white
adipocytes in mammals. In order to test this hypothesis, we estab-
lished Cisd2-deﬁcient cells, including Cisd2−/− MEFs and Cisd2-
knockdown 3T3-L1 preadipocytes and investigated the essential role
and cell autonomous effect of Cisd2 in the differentiation of white
adipocytes in vitro. The results revealed decreased intracellular lipids,
down-regulation of the expression of adipogenic genes, declined
mitochondrial biogenesis and respiratory function in adipocytes
differentiated from Cisd2-deﬁcient precursor cells. In addition, we
found impaired physiological function of these adipocytes indicated
by insulin insensitivity, defective lipolysis, and decreased secretion of
adiponectin. Most importantly, we demonstrated that the cytosolic
Ca2+ level was increased in Cisd2−/− MEFs. Besides, the activity of
calcineurin, a calcium/calmodulin-dependent phosphatase, was ele-
vated signiﬁcantly in Cisd2−/−MEFs. By using cyclosporine A and FK-
506 to inhibit the activity of calcineurin, the data revealed a recovery
in impaired ability of adipogenic differentiation in Cisd2−/− MEFs.
The above ﬁndings suggest that Cisd2 deﬁciency may induce Ca2+-
calcineurin-dependent retrograde signaling to interrupt the process
of adipogenesis. In addition, we clariﬁed the novel importance of
Cisd2 in differentiation and function of adipocytes and provide a
possible role of Cisd2 in the pathogenesis of systemic dysregulation of
energy metabolism in WFS2.
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CGS7184 is a synthetic large-conductance Ca2+-activated potassium
(BKCa) channel opener. The existing literature suggests that potassi-
um channels are involved in cardioprotection, particularly during
ischemia–reperfusion events. CGS7184 acts on endothelium in the
aorta and coronary circulation, NO production, calcium homeostasis,
and mitochondrial function, especially on mitochondrial membrane
potential, and mitochondrial respiration in cultured endothelial cells.
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